Skip to content

Partner Gregory Sichenzia Quoted on Biotech IPOs

February 22, 2016 – Partner Greg Sichenzia was quoted in a Law360 article titled “More Biotech IPOs Likely To Rely On Insiders Amid Slump.” The article discussed that more biotech companies are relying on support from inside investors to close deals due to  weaker demand in the broader market.  Greg noted that insider participation can…

Read More

SEC Adopts Interim Final Rules to Implement FAST Act

By Avital Perlman On January 13, 2016 the SEC approved interim final rules implementing two provisions of the Fixing America’s Surface Transportation (FAST) Act, adopted by Congress in December, that revise financial reporting forms for emerging growth companies* and smaller reporting companies.** not assigned Avital Even-Shoshan | FAST Act | SEC law | srff

Read More
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.